Filter
215
Filtered Results: 215
Text search:
myocarditis
Featured
Recommendations
30
New Publications
29
Language
Document type
Guidelines
85
No document type
74
Studies & Reports
30
Manuals
12
Fact sheets
11
Training Material
2
Resource Platforms
1
Countries / Regions
India
15
Latin America and the Carribbean
10
Argentina
10
Brazil
8
Global
7
Venezuela
6
Paraguay
6
Indonesia
6
Colombia
5
Africa
5
Germany
5
South Africa
5
Rwanda
4
Bolivia
3
Ecuador
3
El Salvador
2
Philippines
2
Mozambique
2
USA
2
Tanzania
2
West and Central Africa
2
Western and Central Europe
2
Bangladesh
2
Nepal
1
Kenya
1
Ukraine
1
Lesotho
1
Ghana
1
Sierra Leone
1
Chile
1
Nigeria
1
Peru
1
Malawi
1
Zimbabwe
1
Congo, Democratic Republic of
1
Western Pacific Region
1
East and Southern Africa
1
Uganda
1
Nicaragua
1
Russia
1
Ethiopia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Guidelines
66
COVID-19
34
Studies & Reports
15
Chagas
8
Clinical Guidelines
6
NTDs & Others
6
Pediatrics
5
Vaccine-preventable Diseases
5
Drugs & Medical Equipment
5
Women & Child Health
5
Communicable Diseases
4
Paediatrics
4
Dermatology
4
Capacity Building
4
Immunization
4
Communicable Diseases
4
Dengue
4
Non-communicable Diseases
4
HIV & STI
4
Disease Prevention & Control
4
Cardiovascular Diseases
3
Policies & Guidelines HIV & TB
3
Surgery & Anaesthesia
3
Dental & Eye Care
2
Child Health
2
Vector Control
2
Yellow Fever
2
Zika
1
Under-5 nutrition
1
Diabetes
1
Bacteriology
1
Humanitarian Aid
1
MPOX - Monkeypox
1
Maternal & Child Health
1
NCD
1
Hemorrhagic Fever
1
Policies
1
Statistics
1
General Guidelines
1
Gynaecology & Obstetrics
1
Key Resources
1
Toolboxes
Country specific documents
26
Long COVID/ Post-COVID Syndrome
13
Clinical Guidelines
11
Immunization Guidelines
7
Biontech/Pfizer Comirnaty
7
Moderna
6
Studies & Reports
5
Studies & Reports
5
Dengue
4
Inactivated COVID-19 Vaccines
4
Chagas
4
Surveillance
3
Paediatrics
3
Johnson & Johnson
3
Handbooks & Manuals
3
Overview, Studies & Reports
3
Substance Use Disorders & Addiction
3
Alcohol
2
Yellow Fever
2
Vaccination
2
Context & Facts, Travel Advice
2
Scientific & Research Studies
2
Communication Material
2
COVID-19 Vaccination
2
COVID-19 Vaccination Information
2
Booster Doses
2
Model Formulary
2
Mental Disorders
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Information & Education Material (IEC)
2
Clinical Aspects & Diagnosis
2
Prevention & Strategies
2
Studies & Reports
2
Chikungunya
2
Assessment & Studies
1
Meningitis Prevention & Control
1
Laboratory Guidance
1
Clinical Aspects, Treatment & Prevention
1
Treatment & Prevention
1
Clinical Aspects
1
Country specific
1
Influenza Prevention & Control
1
Diagnosis & Treatment PTSD in Children
1
Substance Use Disorders, Others
1
Influenza
1
Context, Facts & Travel Advice
1
Opoids
1
Stroke
1
Public Health
1
Laboratory & Sampling
1
Clinical Guidelines
1
Clinical Aspects
1
Diagnostics & Laboratory Guidance
1
Country Specific
1
Oxygen Therapy
1
Essential Medicines & Medical Devices
1
Blood Supply
1
Long-term Care Facilities
1
Logistics & Supply
1
mRna Vaccines general
1
Others
1
Reports & Studies
1
Guidelines & Manuals
1
Zoonoses
1
Non-communicable Diseases NCD
1
MPOX - Monkeypox
1
NTDs
1
Dengue & Chikungunya
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Studies & Reports
1
NTDs General
1
Vector control
1
Leptospirosis
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
Bipolar Affective Disorders
1
Prophylactic Treatment
1
Education of students & professionals
1
Self-harm & Suicide
1
Germany
1
Dengue Prevention & Control
1
Latin America & the Carribean
1
Clinical Guidelines
1
Chikungunya Prevention & Control
1
Anxiety Disorders
1
Antiretroviral Treatment ART
1
Depression
1
Case Definitions
1
Volunteers
1
Reports & Studies
1
Vaccination
1
Blue Book. The Medical Guide for our Projects
recommended
9th edition; 4th English edition 2020
The goal of the global outbreak response for monkeypox is to stop human-to-human transmission of monkeypox, with a priority focus on communities at high risk of exposure which may differ according to context, and to effectively use strong public health measures to prevent onward spread of the diseas...
Durante muchos años, la enfermedad de Chagas ha sido una entidad olvidada en nuestro medio, pese a que Colombia posee las condiciones apropiadas para que esta infección se desarrolle y se perpetúe en el tiempo.
Esto se refleja en el poco conocimiento de la enfermedad y en la existencia de muchos...
It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where the disease is endemic, congenital CD (cCD...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the
South of the United States. It is an important cause of early mortality and morbidity, and it is associated with poverty and stigma. A third of
the cases evolve into chronic...
Chagas disease (CD) is caused by Trypanosoma cruzi. When acquired, the
disease develops in stages. For diagnosis, laboratory confirmation is required, and an extensive assessment of the patient’s health should be performed. Treatment consists of the administration of trypanocidal drugs, which may...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
Leptospirosis is an infectious disease caused by pathogenic organisms belonging to the genus Leptospira, that are transmitted directly or indirectly from animals to humans. Leptospirosis is a major direct zoonosis. Humanto-human transmission occurs only very rarely.
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Due to high routine vaccination coverage, overall counts of diphtheria case have significantly declined in the Western Pacific Region recently. However, diphtheria is still prevalent in several countries and areas of the Region and remains a public health issue due to its high case fatality rate.
...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v...
